| Coronavirus vaccine development: from SARS and MERS to COVID-19 YD Li, WY Chi, JH Su, L Ferrall, CF Hung, TC Wu Journal of biomedical science 27, 1-23, 2020 | 520 | 2020 |
| Cervical cancer immunotherapy: facts and hopes L Ferrall, KY Lin, RBS Roden, CF Hung, TC Wu Clinical Cancer Research 27 (18), 4953-4973, 2021 | 176 | 2021 |
| COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection WY Chi, YD Li, HC Huang, TEH Chan, SY Chow, JH Su, L Ferrall, ... Journal of biomedical science 29 (1), 82, 2022 | 137 | 2022 |
| Development of DNA vaccine targeting E6 and E7 proteins of human papillomavirus 16 (HPV16) and HPV18 for immunotherapy in combination with recombinant vaccinia boost and PD-1 … S Peng, L Ferrall, S Gaillard, C Wang, WY Chi, CH Huang, RBS Roden, ... MBio 12 (1), 10.1128/mbio. 03224-20, 2021 | 51 | 2021 |
| A novel pseudovirus‐based mouse model of SARS-CoV-2 infection to test COVID-19 interventions SH Tseng, B Lam, YJ Kung, J Lin, L Liu, YC Tsai, L Ferrall, RBS Roden, ... Journal of biomedical science 28, 1-8, 2021 | 23 | 2021 |
| PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model S Peng, M Tan, YD Li, MA Cheng, E Farmer, L Ferrall, S Gaillard, ... Cancer Immunology, Immunotherapy 70, 1049-1062, 2021 | 20 | 2021 |
| Development of a novel mouse model of spontaneous high-risk HPVE6/E7–expressing carcinoma in the cervicovaginal tract TR Henkle, B Lam, YJ Kung, J Lin, SH Tseng, L Ferrall, D Xing, CF Hung, ... Cancer research 81 (17), 4560-4569, 2021 | 15 | 2021 |
| vaccine update: Vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection., 2022, 29, 82 WY Chi, YD Li, HC Huang, TEH Chan, SY Chow, JH Su, L Ferrall, ... DOI: https://doi. org/10.1186/s12929-022-00853-8, 82, 19 | 10 | 19 |
| Albumin and interferon-β fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+ T cell-mediated antitumor immunity SH Tseng, MA Cheng, E Farmer, L Ferrall, YJ Kung, B Lam, L Lim, TC Wu, ... Journal for immunotherapy of cancer 10 (4), 2022 | 9 | 2022 |
| Control of spontaneous HPV16 E6/E7 expressing oral cancer in HLA-A2 (AAD) transgenic mice with therapeutic HPV DNA vaccine SH Tseng, L Liu, S Peng, J Kim, L Ferrall, CF Hung, TC Wu Journal of biomedical science 28, 1-12, 2021 | 9 | 2021 |
| Development of a spontaneous HPV16 E6/E7-expressing head and neck squamous cell carcinoma in HLA-A2 transgenic mice S Peng, D Xing, L Ferrall, YC Tsai, RBS Roden, CF Hung, TC Wu MBio 13 (1), e03252-21, 2022 | 5 | 2022 |
| Delivery of IL-2 to the T cell surface through phosphatidylserine permits robust expansion of CD8 T cells A MacDonald, B Lam, J Lin, L Ferrall, YJ Kung, YC Tsai, TC Wu, CF Hung Frontiers in immunology 12, 755995, 2021 | 4 | 2021 |
| Targeted tumor coating with antigenic, CTL-recognizable peptides via Annexin A5 chimeric constructs following chemotherapy redirects adaptive CD8+ T cell immunity for tumor … TH Kang, A Yang, Y Tsai, L Ferrall, CF Hung Cellular & Molecular Immunology 18 (6), 1578-1580, 2021 | 4 | 2021 |
| Safety run-in of intramuscular pNGVL4a-Sig/E7 (detox)/HSP70 DNA and TA-CIN protein vaccination as treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1 MH Einstein, RBS Roden, L Ferrall, M Akin, A Blomer, TC Wu, YN Chang Cancer Prevention Research 16 (4), 219-227, 2023 | 2 | 2023 |
| Identification of human MHC-I HPV18 E6/E7-specific CD8+ T cell epitopes and generation of an HPV18 E6/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic mice S Peng, D Xing, L Ferrall, YC Tsai, CF Hung, TC Wu Journal of biomedical science 29 (1), 80, 2022 | 2 | 2022 |
| Safety run-in of intramuscular pNGVL4a-Sig/E7 (detox)/HSP70 and TA-CIN vaccination as the treatment for HPV16 (+) ASCUS, ASC-H, LSIL/CIN-1 (315) M Einstein, R Roden, L Ferrall, YN Chang, A Blomer, TC Wu, MJ Ma Gynecologic Oncology 166, S165, 2022 | | 2022 |
| Erratum for Peng et al.,“Development of a Spontaneous HPV16 E6/E7-Expressing Head and Neck Squamous Cell Carcinoma in HLA-A2 Transgenic Mice” S Peng, D Xing, L Ferrall, YC Tsai, RBS Roden, CF Hung, TC Wu Mbio 13 (2), e00296-22, 2022 | | 2022 |
| Control of Tumors by Antigen‐Specific CD8+ T Cells through PDL1‐Targeted Delivery of Antigenic Peptide PH Feng, X Wang, L Ferrall, TC Wu, CF Hung Journal of immunology research 2022 (1), 9054569, 2022 | | 2022 |
